Cargando…

Disease-modifying drugs for Alzheimer disease: implications for people in Canada

Detalles Bibliográficos
Autores principales:	Watt, Jennifer A., Isaranuwatchai, Wanrudee, Grossman, Linda, Straus, Sharon E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615338/ https://www.ncbi.nlm.nih.gov/pubmed/37903526 http://dx.doi.org/10.1503/cmaj.230595

Ejemplares similares

Should Canadian patients look forward to aducanumab for Alzheimer disease?
por: Watt, Jennifer A., et al.
Publicado: (2021)

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2018)

What Can We Learn From Others to Develop a Regional Centre for Infectious Diseases in ASEAN?: Comment on "Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks"
por: Teerawattananon, Yot, et al.
Publicado: (2022)

A cost-effectiveness analysis of self-debriefing versus instructor debriefing for simulated crises in perioperative medicine in Canada
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2016)

The New Criteria for Alzheimer’s Disease - Implications for Geriatricians(*)
por: Molin, Pierre, et al.
Publicado: (2016)

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease
por: Ritchie, Craig W., et al.
Publicado: (2017)

How can Canada’s health systems improve care for people with chronic obstructive pulmonary disease?
por: Blazer, Alina J., et al.
Publicado: (2023)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Canada’s highest court unchains injection drug users; implications for harm reduction as standard of healthcare
por: Small, Dan
Publicado: (2012)

Implications of Risk Factors for Alzheimer’s Disease in Canada’s Indigenous Population
por: MacDonald, Julia Petrasek, et al.
Publicado: (2015)

How can health technology assessment support our response to public health emergencies?
por: Ananthakrishnan, Aparna, et al.
Publicado: (2022)

Evidence for early disease-modifying drugs in rheumatoid arthritis
por: Scott, David L
Publicado: (2004)

A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types
por: Tricco, Andrea C, et al.
Publicado: (2015)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

“Where does the high road lead?” Potential implications of cannabis legalization for pediatric injuries in Canada
por: Karbakhsh, Mojgan, et al.
Publicado: (2018)

Are biologics more effective than classical disease-modifying antirheumatic drugs?
por: Nurmohamed, Michael T, et al.
Publicado: (2008)

Exploring the Skin Brain Link: Biomarkers in the Skin with Implications for Aging Research and Alzheimer’s Disease Diagnostics
por: Klostermeier, Stefanie, et al.
Publicado: (2023)

Use of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision‐Making Between Patients With Cancer and Clinicians
por: Singh, Namrata, et al.
Publicado: (2023)

Effect of COVID-19 on the mental health care of older people in Canada
por: Flint, Alastair J., et al.
Publicado: (2020)

Les patients canadiens devraient-ils fonder leurs espoirs sur l’aducanumab pour la maladie d’Alzheimer?
por: Watt, Jennifer A., et al.
Publicado: (2021)

Physical activity trails in an urban setting and cardiovascular disease morbidity and mortality in Winnipeg, Manitoba, Canada: a study protocol for a natural experiment
por: Hobin, Erin, et al.
Publicado: (2020)

Frontier injustice: the American threat to Canada’s drug supply
por: Houston, Adam R., et al.
Publicado: (2019)

Implications and reflections on the 2010 Supreme Court ruling on Canada’s AHR Act
por: Deonandan, Raywat, et al.
Publicado: (2011)

Impact of smoking on health system costs among cancer patients in a retrospective cohort study in Ontario, Canada
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2019)

Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
por: Palis, Heather, et al.
Publicado: (2023)

Mitochondria, Diabetes, and Alzheimer’s Disease
por: Milone, Margherita
Publicado: (2012)

The Impact of Alzheimer's Disease in China
por: Wittenberg, Raphael, et al.
Publicado: (2016)

Examination of a non-invasive biomarker for the diagnosis of prodromal Alzheimer's disease and Alzheimer's disease Dementia
por: Dupree, Emmalyn J., et al.
Publicado: (2020)

Increasing SARS-CoV-2 vaccination rates among Black people in Canada
por: Eissa, Azza, et al.
Publicado: (2021)

Assessing Organizational Readiness for Change: Comment on "Development and Content Validation of a Transcultural Instrument to Assess Organizational Readiness for Knowledge Translation in Healthcare Organizations: The OR4KT"
por: Puchalski Ritchie, Lisa M., et al.
Publicado: (2018)

Is immunotherapy an effective treatment for Alzheimer's disease?
por: Licastro, Federico, et al.
Publicado: (2004)

Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011)

Mitophagy and NAD(+) inhibit Alzheimer disease
por: Fang, Evandro F.
Publicado: (2019)

Multi-use physical activity trails in an urban setting and cardiovascular disease: a difference-in-differences analysis of a natural experiment in Winnipeg, Manitoba, Canada
por: McGavock, Jonathan, et al.
Publicado: (2022)

Home-Based Care for People with Alzheimer’s Disease and Related Dementias (ADRD) during COVID-19 Pandemic: From Challenges to Solutions
por: sm-Rahman, Atiqur, et al.
Publicado: (2020)

Researching Prescription Drug Misuse among First Nations in Canada: Starting from a Health Promotion Framework
por: Dell, Colleen Anne, et al.
Publicado: (2012)

How can we improve the interpretation of systematic reviews?
por: Tricco, Andrea C, et al.
Publicado: (2011)

Hospitalization cost of conventional psychiatric care compared to broad-spectrum micronutrient treatment: literature review and case study of adult psychosis
por: Kaplan, Bonnie J., et al.
Publicado: (2017)

Pinpointing key mechanisms in Alzheimer's disease development
por: Williams, Julie
Publicado: (2010)

Alzheimer's disease therapeutic research: the path forward
por: Aisen, Paul S
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gkfujf88421u24md05dejk59b3